טוען...
Mechanisms navigating the TGF-β pathway in prostate cancer
Few pharmacotherapies are currently available to treat castration resistant prostate cancer (CRPC), with low impact on patient survival. Transforming growth factor-β (TGF-β) is a multi-functional peptide with opposite roles in prostate tumorigenesis as an inhibitor in normal growth and early stage d...
שמור ב:
| הוצא לאור ב: | Asian J Urol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Second Military Medical University
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5645057/ https://ncbi.nlm.nih.gov/pubmed/29051866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajur.2015.04.011 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|